FZD7 and neoplasm: FACS analysis demonstrates that approximately 90% of TcdBFBD-bound cells from primary p53/BRCA1-deficient tumors were FZD7+ (S13A Fig), confirming that TcdBFBD targeted FZD7+ cells in tumor tissues.